(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

QUAISAR ENGINE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

QUAISAR ENGINE

ST13

US500000097546259

Classe

9, 42

Pedido

97546259

Registro

7954320

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

23/09/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 42

Data de depósito

12/08/2022

Data de registro

23/09/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

23/09/2025

Última transação

23/09/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

BOSTON, MA

Examinador

SANGID, HANA

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

PSIVANT THERAPEUTICS, INC.
ROIVANT DISCOVERY, INC.
Roivant Sciences GmbH

Representantes

Joyce M. Ferraro FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Classificação técnica

Classes Nice

Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable and recorded computer software for providing, analyzing and generating reports; downloadable and recorded computer software for data processing; electronic apparatus, electronic equipment, namely, computers and graphic processing units, downloadable and recorded software, downloadable and recorded computer programs and downloadable operating system software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable and recorded computer software for database integration; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded software for genetic assessment and identification of diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable and recorded software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical data and images, to analyze data, and to develop pharmaceutical products and chemical compounds; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement

Classe 42

Software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; software as a service (SaaS) for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service (SaaS) for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

23/09/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

23/09/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/08/2025

PUBO

PUBLISHED FOR OPPOSITION

05/08/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

30/07/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

26/06/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

26/06/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

26/06/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

26/06/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

26/06/2025

RDX3

NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED

11/03/2025

RDX1

ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED

11/03/2025

RRDX

ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED

11/03/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

16/12/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/12/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

16/12/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

12/09/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

12/09/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

15/06/2024

GNFR

FINAL REFUSAL E-MAILED

15/06/2024

CNFR

FINAL REFUSAL WRITTEN

15/06/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/04/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/01/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

17/01/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

16/10/2023

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

16/10/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/10/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

17/07/2023

GNRT

NON-FINAL ACTION E-MAILED

17/07/2023

CNRT

NON-FINAL ACTION WRITTEN

17/07/2023

DOCK

ASSIGNED TO EXAMINER

31/05/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

31/08/2022

NWAP

NEW APPLICATION ENTERED

16/08/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace QUAISAR ENGINE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.